September 10, 2020, Filed Under: Lead StoryPeptide-Based Immunotherapy We have developed a fully synthetic, targeted peptide-based immunotherapy for treating Non-small Cell Lung Cancer (Mol Ther. 2015 Jun;23(6):1092-1102). Left image demonstrates tumor cells being destroyed by T cells following treatment with peptide-based immunotherapy Tweet